Keeley-Teton Advisors’s Johnson & Johnson JNJ Stock Holding History

Keeley-Teton Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,627	Closed	-$717K	–	361
2023 Q1	$717K	Buy	4,627 +1	+0%	+$161	0.09%	256
2022 Q4	$817K	Buy	4,626 +2,121	+85%	+$366K	0.1%	237
2022 Q3	$409K	Buy	+2,505	New	+$424K	0.06%	298
2018 Q1	–	Sell	-1,534	Closed	-$214K	–	280
2017 Q4	$214K	Buy	+1,534	New	+$214K	0.01%	269

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Keeley-Teton Advisors's JNJ Position: Q2 2023 in Review

Keeley-Teton Advisors sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 4,627 shares — an estimated $717K sold.

Keeley-Teton Advisors first reported a position in JNJ in Q4 2017 and held it in 4 quarters. The position peaked at $817K in Q4 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

Keeley-Teton Advisors reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
Keeley-Teton Advisors sold 4,627 Johnson & Johnson shares in Q2 2023, an estimated $717K.
Keeley-Teton Advisors first reported a position in Johnson & Johnson in Q4 2017 and held it in 4 quarters.
Keeley-Teton Advisors's Johnson & Johnson position peaked at $817K in Q4 2022.
3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Keeley-Teton Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.